Cleanrooms Explained for Pharmaceutical Microbiology

open79 wyświetleń

The Life Sciences Innovative Manufacturing Fund (LSIMF)

UK registered businesses can apply for funding for life science manufacturing capital investment projects which help increase UK health resilience. The fund provides up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology, with projects requiring a total cost of at least £8 million.

Kto może aplikować

UK registered companies or establishments (wholly private sector) that are product developers, contract development manufacturing organisations, or generics manufacturers. Projects must be capital investments located in the UK with a total eligible cost of at least £8 million.

Źródła

Linki używane przez AI do zebrania informacji o tej dotacji.

Finansowanie

Do £520.0m

Termin

31 marca 2030

Otwarcie

30 października 2024

Strona internetowa organizatora Zobacz źródło

Zarejestruj się, aby automatycznie dopasowywać się do takich dotacji.

Zacznij za darmo

Kryteria kwalifikacyjne

Must be a UK registered company or a UK registered establishment with at least one UK registered company in their group structure
Must be a wholly private sector business
Must be a product developer, contract development manufacturing organisation, or a generics manufacturer
Must be able to provide two years of audited accounts for the applicant company (and/or parent entity) or demonstrate that remaining funding is available
Project must have a total eligible cost of at least £8 million
Project must be located in the UK
Project must be primarily a capital investment
Project must be a single company investment or joint investment within the same company group structure

The Life Sciences Innovative Manufacturing Fund (LSIMF)

Źródła

Similar grants